NorthWest Biotherapeutics Inc (NWBO)

[extrooper]

I don’t understand those who criticize DCVax-L and the exceptional clinical results. The accolades given by the survivors and their families, along with world renowned experts, reputable articles who have applauded the results and the MHRA who gave DCVax-L their blessings by assigning it as the first therapy in the UK Special Program for early use by general public , are reason enough to believe in the success.